Clinical Trials Directory

Trials / Unknown

UnknownNCT02939833

Effects of Scalp Nerve Blocks on Systemic Inflammation

Effects of Scalp Nerve Blocks on Systemic Inflammation After Meningeoma Resection Surgery:a Prospective Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing meningeoma resection surgery will be randomly assigned to two groups. One group will receive scalp nerve blocks with 0.5% ropivacaine, whereas the other group will receive scalp nerve blocks with 0.9% saline after anesthesia induction and before skull-pin insertion. Serum levels of TNF-α、IL-6 and IL-1β will be measured and compared at before surgery, 1h, 24h and 72h after surgery, respectively. VAS score, dosage of pain-control medicine and NRS score at the first three days after surgery, ratio of intracranial infection within 30d after surgery, and total hospitalization days and medical expenditure will also be recorded and compared between the two groups.

Conditions

Interventions

TypeNameDescription
PROCEDUREScalp Nerve Blocks With Ropivacaine
PROCEDUREScalp Nerve Blocks With Saline

Timeline

Start date
2017-01-01
Primary completion
2019-06-01
Completion
2019-10-01
First posted
2016-10-20
Last updated
2016-10-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02939833. Inclusion in this directory is not an endorsement.